GMED vs MRVL · P/E 42, rev $1.55B vs P/E 100, rev $8.19B
Globus Medical (GMED) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Globus Medical (GMED) is a medical devices company listed on US.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
Latest reported MRVL revenue for 2026-01-31 was $8.19B. Net income was $2.67B. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
GMED currently screens at market cap $7.66B and trailing P/E 42.1. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the GMED and MRVL stock pages for the full models.
Not investment advice.